TIDMOPHR
RNS Number : 8663L
Ophir Energy Plc
01 January 2019
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 ("MAR"). UPON THE
PUBLICATION OF THIS ANNOUNCEMENT, THE INSIDE INFORMATION IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN FOR THE PURPOSES OF MAR.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, IN, INTO, OR FROM ANY JURISDICTION WHERE TO DO SO WOULD
CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT
JURISDICTION
THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE
ON TAKEOVERS AND MERGERS (THE "CODE") AND DOES NOT CONSTITUTE AN
ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF
THE CODE. THERE CAN BE NO CERTAINTY THAT ANY OFFER WILL BE MADE
OR
AS TO THE TERMS ON WHICH ANY OFFER MIGHT BE MADE
For immediate release 31 December 2018
Ophir Energy plc
Statement regarding the potential acquisition of Ophir Energy
plc ("Ophir") by PT Medco Energi Global PTE Ltd ("Medco") (a
wholly-owned subsidiary of PT Medco Energi Internasional Tbk).
Further to the share price movement in Ophir, the Boards of
Ophir and Medco confirm they are in discussions about a possible
cash offer to be made by Medco for the entire issued and to be
issued share capital of Ophir.
This announcement does not amount to a firm intention to make an
offer under Rule 2.7 of the Code and there can be no certainty that
any offer will be made, or as to the terms on which any offer might
be made. A further announcement will be made as and when
appropriate.
For the purposes of Rule 2.4(c) of the Code, in accordance with
Rule 2.6(a) of the Code, Ophir announces that, by not later than
5.00 pm on 28 January 2019 (the "Deadline"), Medco must either
announce a firm intention to make an offer for Ophir under Rule 2.7
of the Code or announce that it does not intend to make an offer
for Ophir, in which case the announcement will be treated as a
statement to which Rule 2.8 of the Code applies. The Deadline will
not apply in circumstances where either: (a) it has been either
extended with the consent of the Takeover Panel in accordance with
Rule 2.6(c) of the Code; or (b) Rule 2.6(b) of the Code applies, by
virtue of a firm intention to make an offer for Ophir having been
announced by another offeror prior to the Deadline.
This announcement has been made with the consent of Medco.
Enquiries
Ophir + 44 (0) 20 7811 2400
Geoff Callow, Head of IR and Corporate Communications
Morgan Stanley (Financial Adviser and Corporate Broker to Ophir)
+44 (0) 20 7425 8000
Andrew Foster
Shirav Patel
Investec (Corporate Broker to Ophir) + 44 (0) 20 7597 4000
Chris Sim
Jonathan Wolf
Brunswick (PR Adviser to Ophir)
+ 44 (0) 20 7404 5959
Patrick Handley
Wendel Verbeek
Medco
Investor Relations
Myrta Sri Utami +62 21 29953106
Andhika Suryadharma +62 21 29953150
Standard Chartered Bank - Financial Adviser to Medco
Tom Willett / Kamal Khullar / Karan Soni
Manny Chohhan / Alessandro Ceresa / James +65 6876 0888
McKay +44 (0) 20 7885 8888
Tulchan Communications - Public Relations Adviser to Medco Martin Robinson / Martin Pengelley / Harry
Cameron +44 (0) 20 7353 4200
Angela Campbell-Noë / Chong Yap Tok +65 6222 3765
About Ophir:
Ophir is an independent upstream oil and gas exploration and
production company. It is listed on the London Stock Exchange (LEI:
213800LAZOZTKPAV258).
About Medco:
Medco is a leading Southeast Asian energy and natural resources
company listed on the Jakarta Stock Exchange with a market
capitalisation of approximately USD 900 million, operating across
three key business segments being Oil & Gas, Power and
Mining.
In Oil & Gas, Medco has significant experience in managing
complex and mature onshore and offshore assets and moving
discovered and challenged resources to production, including LNG.
Medco's oil and gas assets are based primarily in Indonesia but it
is focussed on expanding its Southeast Asia presence and adding to
its existing international assets in the Middle East and North
Africa.
Medco also operates gas, geothermal and hydro power plants in
Indonesia through its 88% consolidated interest in Medco Power (12%
held by the International Finance Corporation) and has an effective
39% non-consolidated interest in a large Indonesian copper and gold
mine.
Disclosure requirements of the Code
Under Rule 8.3(a) of the Code, any person who is interested in
1% or more of any class of relevant securities of an offeree
company or of any securities exchange offeror (being any offeror
other than an offeror in respect of which it has been announced
that its offer is, or is likely to be, solely in cash) must make an
Opening Position Disclosure following the commencement of the offer
period and, if later, following the announcement in which any
securities exchange offeror is first identified. An Opening
Position Disclosure must contain details of the person's interests
and short positions in, and rights to subscribe for, any relevant
securities of each of (i) the offeree company and (ii) any
securities exchange offeror(s). An Opening Position Disclosure by a
person to whom Rule 8.3(a) applies must be made by no later than
3.30 pm (London time) on the 10th business day following the
commencement of the offer period and, if appropriate, by no later
than 3.30 pm (London time) on the 10th business day following the
announcement in which any securities exchange offeror is first
identified. Relevant persons who deal in the relevant securities of
the offeree company or of a securities exchange offeror prior to
the deadline for making an Opening Position Disclosure must instead
make a Dealing Disclosure.
Under Rule 8.3(b) of the Code, any person who is, or becomes,
interested in 1% or more of any class of relevant securities of the
offeree company or of any securities exchange offeror must make a
Dealing Disclosure if the person deals in any relevant securities
of the offeree company or of any securities exchange offeror. A
Dealing Disclosure must contain details of the dealing concerned
and of the person's interests and short positions in, and rights to
subscribe for, any relevant securities of each of (i) the offeree
company and (ii) any securities exchange offeror(s), save to the
extent that these details have previously been disclosed under Rule
8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies
must be made by no later than 3.30 pm (London time) on the business
day following the date of the relevant dealing.
If two or more persons act together pursuant to an agreement or
understanding, whether formal or informal, to acquire or control an
interest in relevant securities of an offeree company or a
securities exchange offeror, they will be deemed to be a single
person for the purpose of Rule 8.3.
Opening Position Disclosures must also be made by the offeree
company and by any offeror and Dealing Disclosures must also be
made by the offeree company, by any offeror and by any persons
acting in concert with any of them (see Rules 8.1, 8.2 and
8.4).
Details of the offeree and offeror companies in respect of whose
relevant securities Opening Position Disclosures and Dealing
Disclosures must be made can be found in the Disclosure Table on
the Takeover Panel's website at www.thetakeoverpanel.org.uk,
including details of the number of relevant securities in issue,
when the offer period commenced and when any offeror was first
identified. You should contact the Takeover Panel's Market
Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as
to whether you are required to make an Opening Position Disclosure
or a Dealing Disclosure.
Financial advisers
Morgan Stanley & Co. International plc ("Morgan Stanley")
which is authorised by the Prudential Regulation Authority and
regulated by the Financial Conduct Authority and the Prudential
Regulation Authority in the UK is acting as financial adviser
exclusively for Ophir and no one else in connection with the
matters set out in this announcement. In connection with such
matters, Morgan Stanley, its affiliates and their respective
directors, officers, employees and agents will not regard any other
person as their client, nor will they be responsible to any other
person for providing the protections afforded to their clients or
for providing advice in connection with the contents of this
announcement or any other matter referred to herein.
Investec Bank plc ("Investec") is authorised by the Prudential
Regulation Authority and regulated in the United Kingdom by the
Financial Conduct Authority and the Prudential Regulation
Authority. Investec is acting exclusively for Ophir and no one else
in connection with the matters set out in this announcement. In
connection with such matters, Investec will not regard any other
person other than Ophir as their client, nor will Investec be
responsible to anyone other than Ophir for providing the
protections afforded to clients of Investec or for providing advice
in relation to the contents of this announcement or any other
matter referred to in this announcement.
Standard Chartered Bank which is (i) authorised in the United
Kingdom by the Prudential Regulation Authority, and (ii) regulated
in the United Kingdom by the Financial Conduct Authority and the
Prudential Regulation Authority, is acting for Medco and for no one
else in connection with the matters set out in this announcement
and will not be responsible to anyone other than Medco for
providing the protections afforded to clients of Standard Chartered
Bank nor for providing advice in relation to the matters set out in
this announcement.
Website
In accordance with Rule 26.1 of the Code, a copy of this
announcement will be available (subject to certain restrictions
relating to persons resident in restricted jurisdictions) on
Ophir's website at https://www.ophir-energy.com/investors. The
content of this website is not incorporated into, and does not form
part of, this announcement.
Rule 2.9 Requirement
In accordance with Rule 2.9 of the City Code, Ophir confirms
that as at the date of this announcement, it has in issue
707,184,280 ordinary shares of 0.25p each (excluding ordinary
shares held in treasury). The International Securities
Identification Number (ISIN) of the ordinary shares is
GB00B24CT194.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
OFDBBMRTMBBMBJL
(END) Dow Jones Newswires
January 02, 2019 02:00 ET (07:00 GMT)
Ophir Energy (LSE:OPHR)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Ophir Energy (LSE:OPHR)
Historical Stock Chart
Von Jul 2023 bis Jul 2024